Desq Long
Sign in

Company

Vaxcyte, Inc.

PCVX · CIK 0001649094

SEC FORM 4
$79,401.01

Vaxcyte, Inc. (PCVX)

Sale of 1,334 shares at $59.521 per share.

Reporting Person Wassil Jim · Officer Title EVP, Chief Scientific Ofc, COO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001813798-26-000019 · filed 2026-09-09 · View filing →

SEC FORM 4
$431,875.80

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 7,155 shares at $60.36 per share.

Reporting Person GUGGENHIME ANDREW · Officer Title PRESIDENT AND CFO · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001230724-26-000018 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,029,500.16

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 17,056 shares at $60.36 per share.

Reporting Person PICKERING GRANT · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001258693-26-000019 · filed 2026-09-09 · View filing →

SEC FORM 4
$329,505.24

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 5,459 shares at $60.36 per share.

Reporting Person Wassil Jim · Officer Title EVP, Chief Scientific Ofc, COO · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001813798-26-000019 · filed 2026-09-09 · View filing →

SEC FORM 4
$461,814.36

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 7,651 shares at $60.36 per share.

Reporting Person Dhaliwal Harpreet S. · Officer Title Chief Technical Ops Officer · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001886794-26-000012 · filed 2026-09-09 · View filing →

SEC FORM 4
$80,097.72

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 1,327 shares at $60.36 per share.

Reporting Person Cowan Elvia · Officer Title SVP, Finance & CAO · Transaction Code F

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001960048-26-000011 · filed 2026-09-09 · View filing →

SEC FORM 4
$84,461.96

Vaxcyte, Inc. (PCVX)

Sale of 1,381 shares at $61.16 per share.

Reporting Person Wassil Jim · Officer Title EVP, Chief Scientific Ofc, COO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001813798-26-000019 · filed 2026-09-09 · View filing →

SEC FORM 4
$0.00

Vaxcyte, Inc. (PCVX)

Acquisition (code A) of 52,632 shares at $0 per share.

Reporting Person Jodar Luis · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0002151661-26-000004 · filed 2026-09-09 · View filing →

STOCK ACT PTR
$1,001 - $15,000

VAXCYTE INC (PCVX)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded Jul 16, 2026 · Disclosed Sep 4, 2026FILED +50 DAYS

Source: House Clerk PTR · 20035190 · filed 2026-09-04 · View filing →

SEC FORM 4
$88,182.56

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 1,432 shares at $61.58 per share.

Reporting Person GUGGENHIME ANDREW · Officer Title PRESIDENT AND CFO · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001230724-26-000016 · filed 2026-09-02 · View filing →

SEC FORM 4
$211,034.66

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 3,427 shares at $61.58 per share.

Reporting Person PICKERING GRANT · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001258693-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$88,182.56

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 1,432 shares at $61.58 per share.

Reporting Person Wassil Jim · Officer Title CHIEF OPERATING OFFICER · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001813798-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$40,581.22

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 659 shares at $61.58 per share.

Reporting Person Dhaliwal Harpreet S. · Officer Title Chief Technical Ops Officer · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001886794-26-000010 · filed 2026-09-02 · View filing →

SEC FORM 4
$20,075.08

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 326 shares at $61.58 per share.

Reporting Person Cowan Elvia · Officer Title SVP, Finance & CAO · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001960048-26-000009 · filed 2026-09-02 · View filing →

SEC FORM 4
$12,037.50

Vaxcyte, Inc. (PCVX)

Acquisition (code M) of 2,250 shares at $5.35 per share.

Reporting Person Wassil Jim · Officer Title CHIEF OPERATING OFFICER · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001813798-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$93,581.78

Vaxcyte, Inc. (PCVX)

Sale of 1,537 shares at $60.886 per share.

Reporting Person Wassil Jim · Officer Title CHIEF OPERATING OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001813798-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$43,835.95

Vaxcyte, Inc. (PCVX)

Sale of 713 shares at $61.481 per share.

Reporting Person Wassil Jim · Officer Title CHIEF OPERATING OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001813798-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$56,322.42

Vaxcyte, Inc. (PCVX)

Sale of 924 shares at $60.955 per share.

Reporting Person Wassil Jim · Officer Title CHIEF OPERATING OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001813798-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$18,611.47

Vaxcyte, Inc. (PCVX)

Sale of 303 shares at $61.424 per share.

Reporting Person Wassil Jim · Officer Title CHIEF OPERATING OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001813798-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$77,322.02

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 1,273 shares at $60.74 per share.

Reporting Person GUGGENHIME ANDREW · Officer Title PRESIDENT AND CFO · Transaction Code F

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001230724-26-000016 · filed 2026-09-02 · View filing →

SEC FORM 4
$173,837.88

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 2,862 shares at $60.74 per share.

Reporting Person PICKERING GRANT · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code F

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001258693-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$77,322.02

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 1,273 shares at $60.74 per share.

Reporting Person Wassil Jim · Officer Title CHIEF OPERATING OFFICER · Transaction Code F

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001813798-26-000017 · filed 2026-09-02 · View filing →

SEC FORM 4
$21,927.14

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 361 shares at $60.74 per share.

Reporting Person Dhaliwal Harpreet S. · Officer Title Chief Technical Ops Officer · Transaction Code F

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001886794-26-000010 · filed 2026-09-02 · View filing →

SEC FORM 4
$14,759.82

Vaxcyte, Inc. (PCVX)

Disposition (code F) of 243 shares at $60.74 per share.

Reporting Person Cowan Elvia · Officer Title SVP, Finance & CAO · Transaction Code F

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001960048-26-000009 · filed 2026-09-02 · View filing →

STOCK ACT PTR
$1,001 - $15,000

VAXCYTE INC (PCVX)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded May 13, 2026 · Disclosed Jun 8, 2026FILED +26 DAYS

Source: House Clerk PTR · 20034713 · filed 2026-06-08 · View filing →

STOCK ACT PTR
$1,001 - $15,000

VAXCYTE INC (PCVX)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded May 12, 2026 · Disclosed Jun 8, 2026FILED +27 DAYS

Source: House Clerk PTR · 20034713 · filed 2026-06-08 · View filing →